In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients.
The federal government is suing some big pharmacy benefit managers, or PBMs, over a system of drug rebates that regulators ...
The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback